Journal of Vascular Surgery
Volume 46, Issue 6, Supplement , Pages S25-S53 , December 2007

Acute venous disease: Venous thrombosis and venous trauma

  • Mark H. Meissner, MD

      Affiliations

    • Department of Surgery, University of Washington School of Medicine, Seattle, Wash
    • Corresponding Author InformationCorrespondence: Mark H. Meissner, MD, Department of Surgery, Box 356410, University of Washington Medical Center, 1589 NE Pacific Street, Seattle, WA 98195.
    • ,
  • Thomas W. Wakefield, MD

      Affiliations

    • Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Mich
    • ,
  • Enrico Ascher, MD

      Affiliations

    • Division of Vascular Surgery, Maimonides Medical Center, Brooklyn, NY
    • ,
  • Joseph A. Caprini, MD

      Affiliations

    • Department of Surgery, Northwest University School of Medicine, Evanston, Ill
    • ,
  • Anthony J. Comerota, MD

      Affiliations

    • Jobst Vascular Center, Toledo, Ohio
    • ,
  • Bo Eklof, MD, PhD

      Affiliations

    • Straub Foundation, Helsingborg, Sweden
    • ,
  • David L. Gillespie, MD

      Affiliations

    • Walter Reed Army Medical Center, Uniformed Services University of the Health Sciences, Potomac, Md
    • ,
  • Lazar J. Greenfield, MD

      Affiliations

    • Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Mich
    • ,
  • Aiwu Ruth He, MD

      Affiliations

    • Division of Hematology-Oncology, Georgetown University Medical Center, Washington DC
    • ,
  • Peter K. Henke, MD

      Affiliations

    • Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Mich
    • ,
  • Anil Hingorani, MD

      Affiliations

    • Division of Vascular Surgery, Maimonides Medical Center, Brooklyn, NY
    • ,
  • Russell D. Hull, MD

      Affiliations

    • Thrombosis Research Unit, Calgary Canada
    • ,
  • Craig M. Kessler, MD

      Affiliations

    • Division of Hematology-Oncology, Georgetown University Medical Center, Washington DC
    • ,
  • Robert D. McBane, MD

      Affiliations

    • Gonda Vascular Center, Mayo Clinic, Rochester, Minn.
    • ,
  • Robert McLafferty, MD

      Affiliations

    • Department of Surgery, Southern Illinois University School of Medicine, Springfield, Ill

Received 16 September 2006 ,Accepted 19 August 2007.

References 

  1. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med. 1991;151:933–938
  2. Nordstrom M, Lindblad B, Bergqvist D, Kjelstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155–160
  3. Coon WW, Willis PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study. Circulation. 1973;48:839–846
  4. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167–1173
  5. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992;152:1660–1664
  6. Oger E, Leroyer C, Le Moigne E, Pomey M-P, Bresolette L, Clavier J, et al. The value of risk factor analysis in clinically suspected deep venous thrombosis. Respiration. 1997;64:326–330
  7. Thomas DP, Merton RE, Hockley DJ. The effect of stasis on the venous endothelium: an ultrastructural study. Br J Haematol. 1983;55:113–122
  8. Myers D, Farris D, Hawley A, Wrobleski S, Chapman A, Stoolman L, et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res. 2002;108:212–221
  9. Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg. 1997;25:816–827
  10. Wakefield TW, Strieter RM, Schaub R, Myers DD, Prince MR, Wrobleski SK, et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg. 2000;31:309–324
  11. Myers DD, Schaub R, Wrobleski SK, Londy FJ, Fex BA, Chapman AM, et al. P-selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb Haemost. 2001;85:423–429
  12. Myers D, Wrobleski S, Londy F, Fex B, Hawley A, Schaub R, et al. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig. Thromb Haemost. 2002;87:374–382
  13. Walenga JM, Jeske WP, Messmore HL. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2000;10(Suppl 1):13–20
  14. Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol. 1998;161:4382–4387
  15. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem. 1999;274:23111–23118
  16. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood. 2002;99:3962–3970
  17. Jy W, Horstman LL, Wang F, Duncan RC, Ahn YS. Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses. Thromb Res. 1995;80:471–482
  18. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg. 2003;38:1075–1089
  19. Hrachovinova I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med. 2003;9:1020–1025
  20. Himber J, Wohlgensinger C, Roux S, Damico LA, Fallon JT, Kirchhofer D, et al. Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost. 2003;1:889–895
  21. Day SM, Reeve JL, Pedersen B, Farris DM, Myers DD, Im M, et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood. 2005;105:192–198
  22. Wakefield TW, Linn MJ, Henke PK, Kadell CA, Wrobleski SK, Sarkar M, et al. Neovascularization during venous thrombus organization: A preliminary study. J Vasc Surg. 1999;30:885–893
  23. Soo KS, Northeast AD, Happerfield LC, Burnand KG, Bobrow LG. Tissue plasminogen activator production by monocytes in venous thrombolysis. J Pathol. 1996;178:190–194
  24. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001;69:513–521
  25. Grinnell F. Fibronectin and wound healing. J Cell Biochem. 1984;26:107–116
  26. Madlener M, Parks WC, Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res. 1998;242:201–210
  27. Zhu YK, Liu X, Wang H, Kohyama T, Wen FQ, Skold CM, et al. Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. J Allergy Clin Immunol. 2001;108:989–996
  28. Wakefield TW, Strieter RM, Wilke CA, Kadell CA, Wrobleski SK, Burdick MD, et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15:258–268
  29. Stewart GJ. Neutrophils and deep venous thrombosis. Haemostasis. 1993;23(Suppl 1):127–140
  30. Varma MR, Varga AJ, Knipp BS, Sukheepod P, Upchurch GR, Kunkel SL, et al. Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg. 2003;38:1090–1098
  31. Varma MR, Moaveni DM, Dewyer NA, Varga AJ, Deatrick KB, Kunkel SL, et al. Deep vein thrombosis resolution is not accelerated with increased neovascularization. J Vasc Surg. 2004;40:536–542
  32. Henke PK, Wakefield TW, Kadell AM, Linn MJ, Varma MR, Sarkar M, et al. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. J Surg Res. 2001;99:84–91
  33. Henke PK, Varga A, De S, Deatrick CB, Eliason J, Arenberg DA, et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol. 2004;24:1130–1137
  34. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int. 1998;54:2152–2159
  35. Humphries J, McGuiness CL, Smith A, Waltham M, Poston R, Burnand KG. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg. 1999;30:894–900
  36. Waltham M, Burnand KG, Collins M, McGuinness CL, Singh I, Smith A. Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost. 2003;89:169–176
  37. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med. 1995;1:932–937
  38. Sevitt S. The mechanisms of canalisation in deep vein thrombosis. J Pathol. 1973;110:153–165
  39. Sevitt S. Organization of valve pocket thrombi and the anomalies of double thrombi and valve cusp involvement. Br J Surg. 1974;61:641–649
  40. Killewich LA, Bedford GR, Beach KW, Strandness DE. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg. 1989;9:89–97
  41. van Ramshorst B, van Bemmelen PS, Honeveld H, Faber JAJ, Eikelbloom BC. Thrombus regression in deep venous thrombosis (Quantification of spontaneous thrombolysis with duplex scanning). Circulation. 1992;86:414–419
  42. Caps MT, Meissner MH, Tullis MJ, Polissar NL, Manzo RA, Zierler BK, et al. Venous thrombus stability during acute phase of therapy. Vasc Med. 1999;4:9–14
  43. Krupski WC, Bass A, Dilley RB, Bernstein EF, Otis S. Propagation of deep venous thrombosis by duplex ultrasonography. J Vasc Surg. 1990;12:467–475
  44. Meissner MH, Caps MT, Bergelin RO, Manzo RA, Strandness DE. Propagation, rethrombosis, and new thrombus formation after acute deep venous thrombosis. J Vasc Surg. 1995;22:558–567
  45. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362:523–526
  46. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160:761–768
  47. Beyth RJ, Cohen AM, Landefeld CS. Long-term outcome of deep-vein thrombosis. Arch Intern Med. 1995;155:1031–1037
  48. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis. 1975;17:259–270
  49. Kaunitz AM, Hughes JM, Grimes DA, Smith JC, Rochat RW, Kafrissen ME. Causes of maternal mortality in the United States. Obstet Gynecol. 1985;65:605–612
  50. Kistner R, Ball J, Nordyke R, Freeman G. Incidence of pulmonary embolism in the course of thrombophlebitis of the lower extremities. Am J Surg. 1972;124:169–176
  51. Plate G, Ohlin P, Eklof B. Pulmonary embolism in acute ileofemoral venous thrombosis. Br J Surg. 1985;72:912–915
  52. Lindner DJ, Edwards JM, Phinney ES, Taylor LM, Porter JM. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. J Vasc Surg. 1986;4:436–442
  53. Monreal M, Martorell A, Callejas J, Valls R, Llamazares J, Lafoz E, et al. Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic syndrome: a prospective trial. J Intern Med. 1993;233:233–238
  54. Prandoni P, Lensing A, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7
  55. Prandoni P, Villalta S, Polistena P, Bernardi E, Cogo A, Girolami A. Symptomatic deep-vein thrombosis and the post-thrombotic syndrome. Haematologica. 1995;80:42–48
  56. Strandness DE, Langlois Y, Cramer M, Randlett A, Thiele BL. Long-term sequelae of acute venous thrombosis. JAMA. 1983;250:1289–1292
  57. Johnson BF, Manzo RA, Bergelin RO, Strandness DE. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: A one- to six- year follow-up. J Vasc Surg. 1995;21:307–313
  58. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg. 1993;18:596–608
  59. Gooley NA, Sumner DS. Relationship of venous reflux to the site of venous valvular incompetence: implications for venous reconstructive surgery. J Vasc Surg. 1988;7:50–59
  60. Rosfors S, Lamke LO, Nordstroem E, Bygdeman S. Severity and location of venous valvular insufficiency: the importance of distal valve function. Acta Chir Scand. 1990;156:689–694
  61. van Bemmelen PS, Bedford G, Beach K, Strandness DE. Status of the valves in the superficial and deep venous system in chronic venous disease. Surgery. 1991;109:730–734
  62. Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162:1245–1248
  63. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism (A population-based case-control study). Arch Intern Med. 2000;160:809–815
  64. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–593
  65. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259–262
  66. Census UBot. Statistical abstract of the United States: 2000. 120th ed.. 2000;Washington, DC
  67. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338S–400S
  68. Frankel HL, FitzPatrick MK, Gaskell S, Hoff WS, Rotondo MF, Schwab CW. Strategies to improve compliance with evidence-based clinical management guidelines. J Am Coll Surg. 1999;189:533–538
  69. Shojania K, Duncan B, McDonald V. Making health care safer: a critical analysis of patient safety practices (Evidence report/Technolgy assessment No. 43). AHRQ Publication No. 01-EO58 Agency for healthcare research and quality. 2001;332–346
  70. Goldhaber SZ. Prevention of recurrent idiopathic venous thromboembolism. Circulation. 2004;110:IV20–IV24
  71. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991;115:591–595
  72. Pini M, Froehlich J, Bergmann JF, Monreal M, Piovella F, Huang W, et al. Comparison of US and European practices in the prevention of venous thromboembolism in hospitalized medical patients: Findings of the International Medical Prevention Registry of VTE (IMPROVE). Blood. 2003;102(Suppl):1151
  73. Rahim SA, Panju A, Pai M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res. 2003;111:215–219
  74. Tapson VF, Decousus H, Piovella F. A multinational observational cohort study in acutely ill medical patients of practices in prevention of VTE: findings of the International Medical Prevention Registry of VTE (IMPROVE). Blood. 2003;102(Suppl):321a
  75. Tapson VF, Goldhaber SZ. Failure to prophylax for deep venous thrombosis: results of the DVT FREE study. Blood. 2003;2003:1156
  76. Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest. 2005;128:958–969
  77. Williams JG, Cheung WY, Price DE, Tansey R, Russell IT, Duane PD, et al. Clinical guidelines online: do they improve compliance?. Postgrad Med J. 2004;80:415–419
  78. Tooher R, Middleton P, Pham C, Fitridge R, Rowe S, Babidge W, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg. 2005;241:397–415
  79. Hirsh J, Guyatt G, Albers GW, Schunemann HJ. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy (Evidence-based guidelines). Chest. 2004;126:172S–173S
  80. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:401S–428S
  81. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:188S–203S
  82. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med. 1997;157:2562–2568
  83. Prandoni P, Carnovali M, Marchiori A. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Arch Intern Med. 2004;164:1077–1083
  84. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:287S–310S
  85. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:311S–337S
  86. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:204S–233S
  87. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis (Warfarin Optimal Duration Italian Trial Investigators). N Engl J Med. 2001;345:165–169
  88. Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA. 2003;290:1071–107427
  89. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137:955–960
  90. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146–153
  91. Akesson H, Brudin L, Dahlstrom JA, Eklof B, Ohlin P, Plate G. Venous function assessed during a 5-year period after acute iliofemoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg. 1990;4:43–48
  92. O’Donnell TF, Browse NL, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res. 1977;22:483–488
  93. Shull KC, Nicolaides AN, Fernandes e Fernandes J, Miles C, Horner J, Needham T, et al. Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg. 1979;114:1304–1306
  94. Cho JS, Martelli E, Mozes G, Miller VM, Gloviczki P. Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function. J Vasc Surg. 1998;28:787–799
  95. Rhodes JM, Cho JS, Gloviczki P, Mozes G, Rolle R, Miller VM. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg. 2000;31:1193–1205
  96. Markel A, Manzo RA, Bergelin RO, Strandness DE. Valvular reflux after deep vein thrombosis: incidence and time of occurrence. J Vasc Surg. 1992;15:377–384
  97. Plate G, Akesson H, Einarsson E, Ohlin P, Eklof B. Long-term results of venous thrombectomy combined with a temporary arterio-venous fistula. Eur J Vasc Surg. 1990;4:483–489
  98. Plate G, Einarsson E, Ohlin P, Jensen R, Qvarfordt P, Eklof B. Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg. 1984;1:867–876
  99. Plate G, Eklof B, Norgren L, Ohlin P, Dahlstrom JA. Venous thrombectomy for iliofemoral vein thrombosis--10-year results of a prospective randomised study. Eur J Vasc Endovasc Surg. 1997;14:367–374
  100. Comerota A, Aldridge S. Thrombolytic therapy for acute deep venous thrombosis. Semin Vasc Surg. 1992;5:76–81
  101. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984;76:393–397
  102. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA, Caldwell MD, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405–418
  103. Comerota AJ, Kagan SA. Catheter-directed thrombolysis for the treamtent of acute iliofemoral vein thrombosis. Phlebology. 2001;15:149–155
  104. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis of lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49
  105. Comerota AJ, Throm RC, Mathias SD, Haughton SH, Mewissen MW. Catheter-directed thrombolysis for iliofemoral deep vein thrombosis improves health-related quality of life. Vasc Surg. 2000;2000:130–137
  106. Chang R, Cannon RO, Chen CC, Doppman JL, Shawker TH, Mayo DJ, et al. Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity. J Vasc Interv Radiol. 2001;12:247–252
  107. Shortell CK, Queiroz R, Johansson M, Waldman D, Illig KA, Ouriel K, et al. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion. J Vasc Surg. 2001;34:854–859
  108. Verhaeghe R, Stockx L, Lacroix H, Vermylen J, Baert AL. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol. 1997;7:996–1001
  109. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis (A randomised clinical trial). Eur J Vasc Endovasc Surg. 2002;24:209–214
  110. Eklof B, Kasirajan K. Treating proximal deep vein thrombosis. Endovascular Today. 2003;April:17–23
  111. Elklof B, Rutherford RB. Surgical thrombectomy for acute deep venous thrombosis. In:  Rutherford RB editors. Vascular surgery. 6th ed.. Philadelphia: Elsevier Saunders; 2005;p. 2188–2198
  112. Blattler W, Heller G, Largiader J, Savolainen H, Gloor B, Schmidli J. Combined regional thrombolysis and surgical thrombectomy for treatment of iliofemoral vein thrombosis. J Vasc Surg. 2004;40:620–625
  113. Endrys J, Eklof B, Neglen P, Zyka I, Peregrin J. Percutaneous balloon occlusion of surgical arteriovenous fistulae following venous thrombectomy. Cardiovasc Intervent Radiol. 1989;12:226–229
  114. Magnant JG, Walsh DB, Juravsky LI, Cronenwett JL. Current use of inferior vena cava filters. J Vasc Surg. 1992;16:701–706
  115. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140:589–602
  116. Greenfield LJ, Proctor MC. Current indications for caval interruption: should they be liberalized in view of improving technology?. Semin Vasc Surg. 1996;9:50–58
  117. Greenfield LJ, Proctor MC. Suprarenal filter placement. J Vasc Surg. 1998;28:432–438discussion 8
  118. Ascher E, Hingorani A, Mazzariol F, Jacob T, Yorkovich W, Gade P. Clinical experience with superior vena caval Greenfield filters. J Endovasc Surg. 1999;6:365–369
  119. Berry R, George J, Shaver W. Free-floating deep venous thrombosis (A retrospective analysis). Ann Surg. 1990;211:719–723
  120. Langan EM, Miller RS, Casey WJ, Carsten CG, Graham RM, Taylor SM. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment. J Vasc Surg. 1999;30:484–488
  121. Sugerman HJ, Sugerman EL, Wolfe L, Kellum JM, Schweitzer MA, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41–46
  122. Thery C, Bauchart JJ, Lesenne M, Asseman P, Flajollet JG, Legghe R, et al. Predictive factors of effectiveness of streptokinase in deep venous thrombosis. Am J Cardiol. 1992;69:117–122
  123. Peyton JW, Hylemon MB, Greenfield LJ, Crute SL, Sugerman HJ, Quershi GD. Comparison of Greenfield filter and vena caval ligation for experimental septic thromboembolism. Surgery. 1983;93:533–537
  124. Chiou AC, Matsumura JS. Bedside placement of IVC filters. Endovascular Today. 2005;4:60–63
  125. Hanrahan LM, Araki CT, Fisher JB, Rodriguez AA, Walker G, Woodson J, et al. Evaluation of the perforating veins of the lower extremity using high resolution duplex imaging. J Cardiovasc Surg. 1991;32:87–97
  126. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999;19:511–518
  127. Margaglione M, Brancaccio V, Giuliani N, D’Andrea G, Cappucci G, Iannaccone L, et al. Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med. 1998;129:89–93
  128. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost. 1997;77:444–451
  129. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women (Implications for venous thromboembolism screening). JAMA. 1997;277:1305–1307
  130. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706–708
  131. Hobikoglu GF, Akyuz U, Akyuz F, Ozer O, Guney D, Narin A, et al. Factor V leiden is a risk factor for myocardial infarction in young Turkish men. Acta Cardiol. 2004;59:594–597
  132. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504–1508
  133. Brill-Edwards P, Ginsberg JS, Gent M, Hirsh J, Burrows R, Kearon C, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism (Recurrence of Clot in This Pregnancy Study Group). N Engl J Med. 2000;343:1439–144416
  134. Kennedy M, Andreescu AC, Greenblatt MS, Jiang H, Thomas CA, Chassereau L, et al. Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients. Br J Haematol. 2005;128:386–388
  135. Verlato F, Zucchetta P, Prandoni P, Camporese G, Marzola MC, Salmistraro G, et al. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. J Vasc Surg. 1999;30:1113–1115
  136. De Weese MS. Nonoperative treatment of acute superficial thrombophlebitis and deep femoral venous thrombosis. In:  Ernst CB,  Stanley JC editor. Current therapy in vascular surgery. Philadelphia: B.C. Decker, Inc; 1991;p. 952–960
  137. Lohr JM, McDevitt DT, Lutter KS, Roedersheimer LR, Sampson MG. Operative management of greater saphenous thrombophlebitis involving the saphenofemoral junction. Am J Surg. 1992;164:269–275
  138. Lutter KS, Kerr TM, Roedersheimer LR, Lohr JM, Sampson MG, Cranley JJ. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery. 1991;110:42–46
  139. Hanson JN, Ascher E, DePippo P, Lorensen E, Scheinman M, Yorkovich W, et al. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease. J Vasc Surg. 1998;27:677–680
  140. Bjorgell O, Nilsson PE, Jarenros H. Isolated nonfilling of contrast in deep vein segments seen on phlebography, and a comparison with color Doppler ultrasound to assess the incidence of deep venous thrombosis. Angiology. 2000;51:451–461
  141. Jorgensen JO, Hanel KC, Morgan AM, Hunt JM. The incidence of deep venous thrombosis in patients with superficial thrombophlebitis of the lower limbs. J Vasc Surg. 1993;18:70–73
  142. Skillman JJ, Kent KC, Porter DH, Kim D. Simultaneous occurrence of superficial and deep thrombophlebitis in the lower extremity. J Vasc Surg. 1990;11:818–823discussion 23-4
  143. Talbot S. Use of real-time imaging in identifying deep venous obstruction: a preliminary report. Bruit. 1982;VI:41–42
  144. Hobbs JT. Superficial thrombophlebitis. In:  Hobbs JT editors. The treatment of venous disorders. Philadelphia: J. B. Lippincott; 1977;p. 414–427
  145. Ludbrook J, Jamieson G. Disorders of veins. In:  Sabiston DCJ editors. Textbook of Surgery. 12th ed.. Philadelphia: WB Saunders; 1981;p. 1808–1827
  146. Chengelis DL, Bendick PJ, Glover JL, Brown OW, Ranval TJ. Progression of superficial venous thrombosis to deep vein thrombosis. J Vasc Surg. 1996;24:745–749
  147. Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg. 1998;27:338–343
  148. Gjores JE. Surgical therapy of ascending thrombophlebitis in the saphenous system. Angiology. 1962;13:241–243
  149. Husni EA, Williams WA. Superficial thrombophlebitis of lower limbs. Surgery. 1982;91:70–74
  150. Lofgren EP, Lofgren KA. The surgical treatment of superficial thrombophlebitis. Surgery. 1981;90:49–54
  151. Plate G, Eklof B, Jensen R, Ohlin P. Deep venous thrombosis, pulmonary embolism and acute surgery in thrombophlebitis of the long saphenous vein. Acta Chir Scand. 1985;151:241–244
  152. Leon L, Giannoukas AD, Dodd D, Chan P, Labropoulos N. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg. 2005;29:10–17
  153. Ascer E, Lorensen E, Pollina RM, Gennaro M. Preliminary results of a nonoperative approach to saphenofemoral junction thrombophlebitis. J Vasc Surg. 1995;22:616–621
  154. Belcaro G, Nicolaides AN, Errichi BM, Cesarone MR, De Sanctis MT, Incandela L, et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology. 1999;50:523–529
  155. Sullivan V, Denk PM, Sonnad SS, Eagleton MJ, Wakefield TW. Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system. J Am Coll Surg. 2001;193:556–562
  156. Neher JO, Safranek S, Greenwald JL. Clinical inquiries (What is the best therapy for superficial thrombophlebitis?). J Fam Pract. 2004;53:583–585
  157. Rich NM, Hobson RW, Wright CB, Fedde CW. Repair of lower extremity venous trauma: a more aggressive approach required. J Trauma. 1974;14:639–652
  158. DeBakey ME, Simeone FA. Surgery in World War II - Vascular surgery. Washington, DC: Office of the United States Surgeon General; 1955;
  159. Makins GH. Gunshot injuries to the blood vessels. Bristol, UK: John Wright and Sons; 1919;
  160. DeBakey ME, Simeone FA. Battle injuries of the arteries in World War II: an analysis of 2471 cases. Ann Surg. 1946;123:534–579
  161. Hughes CW. Acute vascular trauma in Korean War casualties (an analysis of 180 cases). In:  Howard JM,  Hughes CW,  Crosby WH,  Artz CP,  Meroney WH editor. Battle casualties in Korea: studies of the surgical research team. Washington, DC: Army Medical Services Graduate School; 1955;p. 132–147
  162. Rice DP, MacKenzie EJ. Cost of injury in the United States: a report to Congress. In: IoHa  editors. Aging Baltimore: Johns Hopkins University; 1989;
  163. Hughes CW, Cohen A. The repair of injured blood vessels. Surg Clin North Am. 1958;38:1529–1543
  164. Rich NM, Hughes CW. Vietnam vascular registry: a preliminary report. Surgery. 1969;65:218–226
  165. Rich NM, Baugh JH, Hughes CW. Acute arterial injuries in Vietnam: 1000 cases. J Trauma. 1970;10:359–369
  166. Rich NM, Hughes CW, Baugh JH. Management of venous injuries. Ann Surg. 1970;171:724–730
  167. Feliciano DV, Herskowitz K, O’Gorman RB, Cruse PA, Brandt ML, Burch JM, et al. Management of vascular injuries in the lower extremities. J Trauma. 1988;28:319–328
  168. Hardin WD, Adinolfi MF, O’Connell RC, Kerstein MD. Management of traumatic peripheral vein injuries (Primary repair or vein ligation). Am J Surg. 1982;144:235–238
  169. Hobson RW, Yeager RA, Lynch TG, Lee BC, Jain K, Jamil Z, et al. Femoral venous trauma: techniques for surgical management and early results. Am J Surg. 1983;146:220–224
  170. Menzoian JO, Doyle JE, LoGerfo FW, Cantelmo N, Weitzman AF, Sequiera JC. Evaluation and management of vascular injuries of the extremities. Arch Surg. 1983;118:93–95
  171. Fox CJ, Gillespie DL, O’Donnell SD, Rasmussen TE, Goff JM, Johnson CA, et al. Contemporary management of wartime vascular trauma. J Vasc Surg. 2005;41:638–644
  172. Gaspar MR, Treiman RL. The management of injuries to major veins. Am J Surg. 1960;100:171–175
  173. Smith LM, Block EF, Buechter KJ, Draughn DC, Watson D, Hedden W. The natural history of extremity venous repair performed for trauma. Am Surg. 1999;65:116–120
  174. Gagne PJ, Cone JB, McFarland D, Troillett R, Bitzer LG, Vitti MJ, et al. Proximity penetrating extremity trauma: the role of duplex ultrasound in the detection of occult venous injuries. J Trauma. 1995;39:1157–1163
  175. Gerlock AJ, Thal ER, Snyder WH. Venography in penetrating injuries of the extremities. AJR Am J Roentgenol. 1976;126:1023–1027
  176. Kanne JP, Lalani TA. Role of computed tomography and magnetic resonance imaging for deep venous thrombosis and pulmonary embolism. Circulation. 2004;109:I15–I21
  177. Butty S, Hagspiel KD, Leung DA, Angle JF, Spinosa DJ, Matsumoto AH. Body MR venography. Radiol Clin North Am. 2002;40:899–919
  178. Barcia PJ, Nelson TG, Whelan TJ. Importance of venous occlusion in arterial repair failure: an experimental study. Ann Surg. 1972;175:223–227
  179. Hobson RW, Howard EW, Wright CB, Collins GJ, Rich NM. Hemodynamics of canine femoral venous ligation: significance in combined arterial and venous injuries. Surgery. 1973;74:824–829
  180. Wright CB, Swan KG, Reynolds DG, Nelson TG. Venous occlusion in the canine hindlimb: Hemodynamic effects of adrenergic stimulation and blockade. Surgery. 1973;73:507–511
  181. Wright CB, Hobson RW. Hemodynamic effects of femoral venous occlusion in the subhuman primate. Surgery. 1974;75:453–460
  182. Hughes CW, Bowers WF. Traumatic lesions of peripheral vessels. Springfield, (IL): Charles C. Thomas; 1961;
  183. Rich NM. Principles and indications for primary venous repair. Surgery. 1982;91:492–496
  184. Rich NM. Management of venous trauma. Surg Clin North Am. 1988;68:809–821
  185. Rich NM. Complications of vascular injury management. Surg Clin North Am. 2002;82:143–174xxi
  186. Rich NM, Clagett GP, Salander JM, Gabellon S, Eddleman WL. Surgical treatment of arterial and venous injuries. Acta Chir Belg. 1982;82:473–484
  187. Rich NM, Collins GJ, Andersen CA, McDonald PT. Autogenous venous interposition grafts in repair of major venous injuries. J Trauma. 1977;17:512–520
  188. Rich NM, Hobson RW. Venous trauma: emphasis for repair is indicated. J Cardiovasc Surg (Torino). 1973;Spec No:571–575
  189. Rich NM, Hobson RW, Collins GJ, Andersen CA. The effect of acute popliteal venous interruption. Ann Surg. 1976;183:365–368
  190. Rich NM, Rhee P. An historical tour of vascular injury management: from its inception to the new millennium. Surg Clin North Am. 2001;81:1199–1215
  191. Pappas PJ, Haser PB, Teehan EP, Noel AA, Silva MB, Jamil Z, et al. Outcome of complex venous reconstructions in patients with trauma. J Vasc Surg. 1997;25:398–404
  192. Menzoian JO, LoGerfo FW, Doyle JE, Hirsch EF, Nowak M, Sequeira JC, et al. Management of vascular injuries to the leg. Am J Surg. 1982;144:231–234
  193. Meyer J, Walsh J, Schuler J, Barrett J, Durham J, Eldrup-Jorgensen J, et al. The early fate of venous repair after civilian vascular trauma (A clinical, hemodynamic, and venographic assessment). Ann Surg. 1987;206:458–464
  194. Parry NG, Feliciano DV, Burke RM, Cava RA, Nicholas JM, Dente CJ, et al. Management and short-term patency of lower extremity venous injuries with various repairs. Am J Surg. 2003;186:631–635
  195. Ross SE, Ransom KJ, Shatney CH. The management of venous injuries in blunt extremity trauma. J Trauma. 1985;25:150–153
  196. Hobson RW, Popovic N, Croom RD, Rich NM, Bielke SR. Fibrocollagenous tubesin experimental venous reconstruction (Functional and microscopic evaluation). In:  Swan KG editors. Venous surgery in the lower extremity. St. Louis: Warren H. Green Pub, Inc; 1974;
  197. Wright CB, Hobson RW, Swan KG. Autografts and homografts in canine femoral venous reconstruction (A double-blind study). Surgery. 1973;74:654–659
  198. Feliciano DV, Mattox KL, Graham JM, Bitondo CG. Five-year experience with PTFE grafts in vascular wounds. J Trauma. 1985;25:71–82
  199. Shah DM, Leather RP, Corson JD, Karmody AM. Polytetrafluoroethylene grafts in the rapid reconstruction of acute contaminated peripheral vascular injuries. Am J Surg. 1984;148:229–233
  200. Whelan TJ, Burkhalter WE, Gomez A. Management of war wounds. 1968;In: Office of the US Surgeon General, editor
  201. Shah PM, Ito K, Clauss RH, Babu SC, Reynolds BM, Stahl WM. Expanded microporous polytetrafluoroethylene (PTFE) grafts in contaminated wounds: experimental and clinical study. J Trauma. 1983;23:1030–1033
  202. Stone KS, Walshaw R, Sugiyama GT, Dean RE, Dunstan RW. Polytetrafluoroethylene versus autogenous vein grafts for vascular reconstruction in contaminated wounds. Am J Surg. 1984;147:692–695
  203. Bermudez KM, Knudson MM, Nelken NA, Shackleford S, Dean CL. Long-term results of lower-extremity venous injuries. Arch Surg. 1997;132:963–967discussion 7-8
  204. Borman KR, Jones GH, Snyder WH. A decade of lower extremity venous trauma: patency and outcome. Am J Surg. 1987;154:608–612
  205. Zamir G, Berlatzky Y, Rivkind A, Anner H, Wolf YG. Results of reconstruction in major pelvic and extremity venous injuries. J Vasc Surg. 1998;28:901–908
  206. Levin PM, Rich NM, Hutton JE, Barker WF, Zeller JA. Role of arteriovenous shunts in venous reconstruction. Am J Surg. 1971;122:183–191
  207. Hughes CW. Acute vascular trauma in Korean War casualties: an analysis of 180 cases. Surg Gynecol Obstet. 1954;99:91–100
  208. Spencer FC, Grewe RV. The management of arterial injuries in battle casualties. Ann Surg. 1955;141:304–313
  209. Clagett GP, Bowers BL, Lopez-Viego MA, Rossi MB, Valentine RJ, Myers SI, et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg. 1993;218:239–248discussion 48-9
  210. Mullins RJ, Lucas CE, Ledgerwood AM. The natural history following venous ligation for civilian injuries. J Trauma. 1980;20:737–743
  211. Pasch AR, Bishara RA, Schuler JJ, Lim LT, Meyer JP, Merlotti G, et al. Results of venous reconstruction after civilian vascular trauma. Arch Surg. 1986;121:607–611
  212. Wells JK, Hagino RT, Bargmann KM, Jackson MR, Valentine RJ, Kakish HB, et al. Venous morbidity after superficial femoral-popliteal vein harvest. J Vasc Surg. 1999;29:282–289discussion 9-91
  213. Modrall JG, Sadjadi J, Ali AT, Anthony T, Welborn MB, Valentine RJ, et al. Deep vein harvest: predicting need for fasciotomy. J Vasc Surg. 2004;39:387–394
  214. Qvarfordt P, Eklof B, Ohlin P. Intramuscular pressure in the lower leg in deep vein thrombosis and phlegmasia cerulae dolens. Ann Surg. 1983;197:450–453
  215. Saffle JR, Maxwell JG, Warden GD, Jolley SG, Lawrence PF. Measurement of intramuscular pressure in the management of massive venous occlusion. Surgery. 1981;89:394–397
  216. Wright CB, Swan KG. Hemodynamics of venous occlusion in the canine hindlimb. Surgery. 1973;73:141–146
  217. Rich NM, Jarstfer BS, Geer TM. Popliteal artery repair failure: causes and possible prevention. J Cardiovasc Surg (Torino). 1974;15:340–351
  218. Brockman SK, Vasko JS. Observations on the pathophysiology and treatment of phlegmasia cerulea dolens with special reference to thrombectomy. Am J Surg. 1965;109:485–492
  219. Timberlake GA, Kerstein MD. Venous injury: to repair or ligate, the dilemma revisited. Am Surg. 1995;61:139–145
  220. Goff JM, Gillespie DL, Rich NM. Long-term follow-up of a superficial femoral vein injury: a case report from the Vietnam Vascular Registry. J Trauma. 1998;44:209–211
  221. Nypaver TJ, Schuler JJ, McDonnell P, Ellenby MI, Montalvo J, Baraniewski H, et al. Long-term results of venous reconstruction after vascular trauma in civilian practice. J Vasc Surg. 1992;16:762–768
  222. Phifer TJ, Gerlock AJ, Rich NM, McDonald JC. Long-term patency of venous repairs demonstrated by venography. J Trauma. 1985;25:342–346
  223. Aitken RJ, Matley PJ, Immelman EJ. Lower limb vein trauma: a long-term clinical and physiological assessment. Br J Surg. 1989;76:585–588
  224. Aita DJ, Kvamme P, Rice JC, Kerstein MD. Venous insufficiency: a late sequelae of four-compartment fasciotomy in the lower extremity?. Am Surg. 1993;59:574–577
  225. Bermudez K, Knudson MM, Morabito D, Kessel O. Fasciotomy, chronic venous insufficiency, and the calf muscle pump. Arch Surg. 1998;133:1356–1361
  226. Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998;92:2353–2358
  227. Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost. 1999;81:198–202
  228. Koster T, Rosendall FR, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet. 1993;342:1503–1506
  229. Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyak K, van der Meer J, et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med. 1998;128:15–20
  230. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703
  231. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls (Study Group for Pooled-Analysis in Venous Thromboembolism). Thromb Haemost. 2001;86:809–816
  232. Koster T, Blann AD, Briet E, Vandenbrouke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152–155
  233. Kraaijenhagen RA, in’t Anker PS, Koopman MMW, Reitsma PH, Prins MH, ven den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83:5–9
  234. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678–3682
  235. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342:696–701
  236. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost. 1998;80:874–877
  237. Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus. 1998;7:15–22
  238. De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost. 1994;72:352–358
  239. Margaglione M, D’Andrea G, Colaizzo D, Cappucci G, del Popolo A, Brancaccio V, et al. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost. 1999;82:1583–1587
  240. van den Belt AG, Sanson BJ, Simioni P, Prandoni P, Buller HR, Girolami A, et al. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med. 1997;157:2227–2232
  241. Lindmarker P. Can all patients with deep vein thrombosis receive low-molecular weight heparin in an outpatient setting. Haemostasis. 1999;29(Suppl 1):84–88
  242. Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation. 1995;92:2800–2802
  243. Simioni P, Prandoni P, Lensing AW, Scudeller A, Sardella C, Prins MH, et al. The risk of recurrent venous thromboembolism in patients with an Arg506- ->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med. 1997;336:399–403
  244. Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, et al. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Arch Intern Med. 2002;162:2357–2360
  245. Palareti G, Legnani C, Cosmi B, Valdre L, Lunghi B, Bernardi F, et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation. 2003;108:313–318
  246. Rintelen C, Pabinger I, Knobl P, Lechner K, Mannhalter C. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost. 1996;75:229–232
  247. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Rossi E, Chiusolo P, et al. The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation. Br J Haematol. 2001;113:630–635
  248. Eichinger S, Minar E, Hirschl M, Bialonczyk C, Stain M, Mannhalter C, et al. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene. Thromb Haemost. 1999;81:14–17
  249. Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene (DURAC Trial Study Group. Duration of Anticoagulation). Thromb Haemost. 1999;81:684–689
  250. Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. J Am Coll Cardiol. 2001;37:215–218
  251. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999;341:801–806
  252. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457–462
  253. den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?. Lancet. 1995;345:882–885
  254. Eichinger S, Stumpflen A, Hirschl M, Bialonczyk C, Herkner K, Stain M, et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost. 1998;80:566–569
  255. Prandoni P, Simioni P, Girolami A. Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thromb Haemost. 1996;75:859
  256. Rance A, Emmerich J, Fiessinger JN. Anticardiolipin antibodies and recurrent thromboembolism. Thromb Haemost. 1997;77:221–222
  257. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy (Duration of Anticoagulation Study Group). Am J Med. 1998;104:332–338

 Competition of interest: none

PII: S0741-5214(07)01368-7

doi: 10.1016/j.jvs.2007.08.037

Journal of Vascular Surgery
Volume 46, Issue 6, Supplement , Pages S25-S53 , December 2007

Article Tools